These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The zebrafish as a model to study polycystic liver disease. Tietz Bogert PS; Huang BQ; Gradilone SA; Masyuk TV; Moulder GL; Ekker SC; Larusso NF Zebrafish; 2013 Jun; 10(2):211-7. PubMed ID: 23668934 [TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of mTOR inhibitor therapy in patients with early-stage autosomal dominant polycystic kidney disease: a meta-analysis of randomized controlled trials. He Q; Lin C; Ji S; Chen J Am J Med Sci; 2012 Dec; 344(6):491-7. PubMed ID: 22902868 [TBL] [Abstract][Full Text] [Related]
45. The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials. Adiamah A; Arif Z; Berti F; Singh S; Laskar N; Gomez D World J Surg; 2019 Jul; 43(7):1788-1801. PubMed ID: 30798417 [TBL] [Abstract][Full Text] [Related]
46. Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease. Temmerman F; Chen F; Libbrecht L; Vander Elst I; Windmolders P; Feng Y; Ni Y; De Smedt H; Nevens F; van Pelt J World J Gastroenterol; 2017 Aug; 23(30):5499-5507. PubMed ID: 28852309 [TBL] [Abstract][Full Text] [Related]
47. [Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Somatostatin analogues and mTOR inhibitors]. Perico N; Cortinovis M; Remuzzi G G Ital Nefrol; 2016; 33(5):. PubMed ID: 27796020 [TBL] [Abstract][Full Text] [Related]
52. Vitamin D supplementation for chronic liver diseases in adults. Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543 [TBL] [Abstract][Full Text] [Related]
53. Development and validation of a polycystic liver disease complaint-specific assessment (POLCA). Temmerman F; Dobbels F; Ho TA; Pirson Y; Vanslembrouck R; Coudyzer W; Bammens B; van Pelt J; Pirenne J; Nevens F J Hepatol; 2014 Nov; 61(5):1143-50. PubMed ID: 24996047 [TBL] [Abstract][Full Text] [Related]
54. Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system. Nunes VS; Correa JM; Puga ME; Silva EM; Boguszewski CL Pituitary; 2015 Aug; 18(4):500-8. PubMed ID: 25261979 [TBL] [Abstract][Full Text] [Related]
55. Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease. Horie S; Muto S; Kawano H; Okada T; Shibasaki Y; Nakajima K; Ibuki T Clin Exp Nephrol; 2021 May; 25(5):467-478. PubMed ID: 33471240 [TBL] [Abstract][Full Text] [Related]
56. Somatostatin analogues in advanced hepatocellular carcinoma: an updated systematic review and meta-analysis of randomized controlled trials. Ji XQ; Ruan XJ; Chen H; Chen G; Li SY; Yu B Med Sci Monit; 2011 Aug; 17(8):RA169-176. PubMed ID: 21804474 [TBL] [Abstract][Full Text] [Related]
57. The relationship between liver cyst volume and QOL in Japanese ADPKD patients. Muto S; Ando M; Nishio S; Hanaoka K; Ubara Y; Narita I; Kamura K; Mochizuki T; Tsuchiya K; Tsuruya K; Horie S Clin Exp Nephrol; 2020 Apr; 24(4):314-322. PubMed ID: 31875934 [TBL] [Abstract][Full Text] [Related]
58. Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study. Billiet A; Temmerman F; Coudyzer W; Van den Ende N; Colle I; Francque S; De Maeght S; Janssens F; Orlent H; Sprengers D; Delwaide J; Decock S; De Vloo C; Moreno C; van Malenstein H; van der Merwe S; Verbeek J; Nevens F United European Gastroenterol J; 2023 Sep; 11(7):633-641. PubMed ID: 37278135 [TBL] [Abstract][Full Text] [Related]
59. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review. Koti RS; Gurusamy KS; Fusai G; Davidson BR HPB (Oxford); 2010 Apr; 12(3):155-65. PubMed ID: 20590882 [TBL] [Abstract][Full Text] [Related]